United States Patient at Home Testing Kits Market Report and Forecast 2024-2032

United States Patient at Home Testing Kits Market Outlook

The United States patient at home testing kits market size is anticipated to grow at a CAGR of 7.94% during the forecast period of 2024-2032, driven by the increasing prevalence of infectious viruses and diseases along with the increasing awareness about self-test kits.

Patient at Home Testing Kits: Introduction

Patient at home testing kits is used to test for particular infection or disease in a person at home. These self-tests are also called home tests or at home tests and over the counter tests. These at-home test kits can simply be used at home with simple instructions to follow. These test kits are convenient, easily available and affordable to be used by anyone. These at-home test kits are reliable and generate almost accurate results. These at-home test kits are also used to pre-diagnose the current medical condition of a patient.

With the use of these at-home test kits the results could be generated in about 10-15 minutes. These tests are most probably antigen tests. In case of detecting viruses these at-home test kits could be fast to generate results but the accuracy of the results may be unreliable as they are different from regular PCR tests.

United States Patient at Home Testing Kits Market Analysis

The market has been witnessing rapid growth and is expected to witness further growth in the coming years with the increasing rate of people visiting healthcare facilities, such as hospitals, clinics frequently in case of the smallest discomfort in their health. The key trends supporting the United States patient at home testing kits market growth include the increasing awareness about self-test kits and related products in the United States, the people are now getting more attracted towards using self-test kits than visit any health care facility first. They like to pre-diagnose themselves first before visiting a healthcare facility or a healthcare professional, which is why the demand is growing.

At-home or self-testing kits are easily available at pharmacies, and it has become extremely easy to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits.

United States Patient at Home Testing Kits Market Segmentations

Market Breakup by Test Type

• Blood Glucose Testing 

• Pregnancy and Fertility Testing 

• HIV Testing 

• Cholesterol Testing  

• Urine Testing 

• COVID-19 Testing 

• Drug Abuse Testing 

• Others

Market Breakup by Sample

• Blood 

• Urine 

• Saliva  

• Others

Market Breakup by Age Group

• Pediatric 

• Adult 

• Geriatric

Market Breakup by Usage

• Disposable 

• Reusables

Market Breakup by Distribution Channel

• Retail Pharmacy Stores 

• Hypermarket/Supermarket 

• E-Commerce 

• Others

United States Patient at Home Testing Kits Market Overview

The increasing prevalence of infectious viruses and diseases is primarily driving the market growth. The adoption of these at-home testing kits by several distribution channels, including offline, pharmacies, and online pharmacies, among others, has rapidly contributed to the growth of the at-home test kits in the United States market, which makes it easier for anyone to avail them at their wish.

Additionally, the increasing technological advancement to enhance the generated outcomes by the test kits is also contributing to the United States patient at home testing kits market growth.

United States patient at home testing kits Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Lucira Health Inc. 

• Essenlix Corporation 

• Abbott Laboratories, Inc. 

• Roche Diagnostics Corporation 

• Siemens Medical Solutions USA, Inc. 

• Thermo Fischer Scientific, Inc. 

• Scanwell Health, Inc. 

• Quidel Corporation 

• GE Healthcare, Inc. 

• ACON Laboratories, Inc.

Key Highlights of the Report